Finance Forum


To build relationships between and among financial professionals throughout the BioNJ Membership and the NJ life sciences ecosystem to foster educational and professional community, information sharing and peer to peer collaboration to facilitate scientific and medical advancement through financial stewardship. Committee members plan and host interactive forums meaningful to its constituents on a variety of topics.

Committee Members

ADMA Biologics, Inc. – Brian Lenz, CPA, Executive Vice President & CFO
EisnerAmper LLP – John Pennett, CPA, Partner-in-Charge, National Life Sciences & Technology Group

Adiso Therapeutics – Scott Megaffin, CEO
Connor Strong & Buckelew – Pat Dillon, Major Accounts, Northeast Region
EY – Tony Torrington, CPA, Partner
EY – Joel Wagner, CPA, Senior Manager
EY – Arda Ural, Ph.D., MSc, MBA, Partner, American Industry Market Leader US East HSW Market Segment Leader
Genmab – Anthony Pagano, MBA, MSc, Executive Vice President & CFO
Hepion Pharmaceuticals, Inc. – John Cavan, MBA, MSc, CFO
Insmed – Sara Bonstein, MBA, Chief Financial Officer
IVERIC Bio, Inc.
– Dave Carroll, CFO
Janssen Global R&D – Jose Azevedo Vice President of Finance, CFO
Matinas Biopharma Holdings, Inc.
– Keith Kucinski, CPA, CFO
PricewaterhouseCoopers LLP – Michael Bey, MBA, Partner
PricewaterhouseCoopers LLP – Chris Pierce, CPA, Partner
RSM – Adam Marshall, Director
Signum Biosciences, Inc. – Michael Losch, MBA, CFO
TYME, Inc. – Barbara Galaini, Principal Accounting Officer & Corporate Controller